Surgery Partners ($NASDAQ:SGRY), Inc., a healthcare services and management company that owns and manages ambulatory surgery centers and surgical hospitals, is projected to have earnings of $0.38 per share in the fourth quarter of 2023. This prediction was made by Defense World, a renowned market analytics firm, and could signal a bright future for the company’s investors. The company provides a number of services, including anesthesia services, ophthalmic services, orthopedic services, urological services, and endoscopy services.
Additionally, Surgery Partners operates its own laboratories and has developed its own software for managing and coordinating patient care. The company has a sound financial position and is well-positioned to capitalize on the increasing demand for outpatient surgical services. Furthermore, its continued innovation and diversification of services also make it a viable option for investors who are looking for a safe and profitable investment.
SURGERY PARTNERS, Inc. has released its earnings report for FY2023 Q2 ending June 30 2021, revealing a total revenue of 543.3M USD and a net income loss of 26.9M USD. This represents a 11.7% decrease in total revenue compared to the same period the previous year. Despite this, SURGERY PARTNERS’s total revenue has still increased from 543.3M USD to 667.6M USD over the last three years.
About the Company
Ownership (Institutional/ Fund Holdings)
Below shows the total revenue, net income and net margin for Surgery Partners. More…
Income Statement Reports (Yearly/ Quarterly/ LTM)
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Surgery Partners. More…
Cash Flow Statement (Yearly/ Quarterly/ LTM)
Cash Flow Supplement
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Surgery Partners. More…
Balance Sheet (Yearly/ Quarterly)
Balance Sheet Supplement
||Book Value Per Share
Key Ratios Snapshot
Some of the financial key ratios for Surgery Partners are shown below. More…
Income Statement Ratios
Balance Sheet Ratios
Cash Flow Ratios
Other Supplementary Items
|3Y Rev Growth
||3Y Operating Profit Growth
On Monday, Surgery Partners, Inc.’s stocks opened at $36.9 and closed at $37.3, up by 1.1% from the prior closing price of 36.9. This news marks a positive outlook for the company as they continue to improve their financials quarter-over-quarter. As such, investors have responded favorably to the news and are optimistic about future results. Live Quote…
GoodWhale has conducted an analysis of SURGERY PARTNERS‘s fundamentals. Based on the Star Chart, SURGERY PARTNERS is classified as a ‘cheetah’, a type of company that is characterized by high revenue or earnings growth, but is considered less stable due to lower profitability. This type of company appeals to a certain type of investor, those with a higher risk tolerance in exchange for potentially greater rewards. SURGERY PARTNERS has a high health score of 8/10 with regards to its cashflows and debt, indicating that the company is capable of sustaining operations in times of crisis. Additionally, SURGERY PARTNERS is strong in asset and growth, medium in profitability, and weak in dividend. This profile further suggests that SURGERY PARTNERS can be an attractive option to those investors willing to take on more risk for potentially greater rewards. More…
Risk Rating Analysis
Star Chart Analysis
It is one of the largest surgical providers in the country and faces competition from other providers such as Cross Country Healthcare Inc, Genesis Healthcare Inc, and PT Mitra Keluarga Karyasehat Tbk. All of these companies provide quality healthcare services for their respective markets and have an established presence in the surgical services sector.
– Cross Country Healthcare Inc ($NASDAQ:CCRN)
Cross Country Healthcare Inc is a leading provider of healthcare staffing and workforce solutions. With a market cap of 1.04 billion as of 2023, the company is well-positioned to capitalize on the growing demand for its services. Cross Country Healthcare Inc’s Return on Equity of 44.54% reflects the fact that the company is generating strong returns for its shareholders. The company offers a variety of solutions, from short-term staffing to long-term strategic workforce planning, that can help healthcare facilities optimize their staffing and operations. With its highly experienced team and industry-leading solutions, Cross Country Healthcare Inc is well positioned to continue to be a leader in the healthcare staffing space.
– Genesis Healthcare Inc ($OTCPK:GENN)
Genesis Healthcare Inc is a leading national provider of post-acute care services, offering long-term care and rehabilitation services at more than 500 skilled nursing centers and assisted/senior living communities in 34 states. As of 2023, the company has a market cap of 1.97M, indicating its relative small size compared to other healthcare providers. Despite its small size, Genesis Healthcare Inc has performed relatively well, evidenced by its Return on Equity of -2.17%. This metric is a measure of how much profit a company is able to generate from its shareholders’ investments, and a negative number indicates that the company is not generating a sufficient return on equity.
– PT Mitra Keluarga Karyasehat Tbk ($IDX:MIKA)
PT Mitra Keluarga Karyasehat Tbk is a leading provider of health and wellness services in Indonesia. The company has a current market cap of 42.7T, making it one of the largest companies in the country. PT Mitra Keluarga Karyasehat Tbk has achieved a remarkable 18.07% Return on Equity, which indicates that the company is able to generate a significant return on its shareholders’ equity. This demonstrates the company’s ability to efficiently manage its resources and generate a healthy return for its shareholders.
Surgery Partners, Inc. is an established company in the healthcare industry providing surgical services and solutions. Analysts have estimated that Surgery Partners will earn a profit of $0.38 per share in the fourth quarter of 2023. This profit projection is based on the company’s current performance – which has been strong across the board – as well as recent changes and initiatives taken by the company.
Investing in Surgery Partners could potentially be a wise choice for those looking for a reliable source of income and a secure long-term investment. With a consistent track record of success and a promising future outlook, investing in Surgery Partners could prove to be a lucrative opportunity.